Skip to main content

Select Drug Profiles

Leukemia, Oncology

Nelarabine Therapy Up Front Boosts Survival in T-Cell Leukemia and Lymphoma

Pancreatic Cancer, Oncology

Timing of Palliative Care Consults Affects Healthcare Utilization in Elderly Patients with Pancreatic Cancer

Practice Management

Discussing Costs with Your Patient Can Reduce Financial Toxicity

Practice Management

Cost of Treating Colorectal Cancer in the United States Double That of Canada, with No Survival Benefit

Practice Management

PARP Inhibitors Least Cost-Effective as Maintenance Therapy in Advanced Ovarian Cancer

Practice Management

Next-Generation Sequencing More Cost-Effective and Faster Than Single-Gene Testing

High Tumor Microsatellite Instability a Marker for Lynch Syndrome, More Common Condition Than Generally Expected

Prostate Cancer

With Access to Care, Black Men in the United States Have Same Prostate Cancer Outcomes as White Men

Lung Cancer, Oncology

Pembrolizumab as a First-Line Standard-of-Care Option in Advanced Non–Small-Cell Lung Cancer See also Value-Based Care

Conference Highlights ASCO, Introduction

Precision Medicine and Immunotherapy Highlighted at ASCO 2018

Page 68 of 244
Results 671 - 680 of 2438